Merck KGaA sales soar
February 21, 2011Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro
Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …
Matt de Gruchy to lead Ogilvy Healthworld UK
February 18, 2011Medical Communications Matt de Gruchy, Ogilvy Healthworld UK, appointment, medical communications
Comms agency Ogilvy Healthworld UK has appointed Matt de Gruchy as chief executive. Matt is a 14 year veteran of …
Digital Pharma: Merck Serono sets up MS social network
February 18, 2011Medical Communications Digital Pharma blog, MS, Merck Serono, Movectro, Rebif, multiple sclerosis, social networking
Merck Serono has set up an international social network for multiple sclerosis patients, saying today’s pharma companies should go beyond …
Merck Serono halts Movectro European licence application
February 18, 2011Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis
Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …
Value-based pricing will not harm industry, says NICE chief
February 18, 2011Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing
NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …
AZ accepts $92.5m to settle respiratory dispute
February 18, 2011Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory
AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …
Trial failures threaten UK biotech
February 18, 2011Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech
A number of late stage failures from British biotech firms have left a looming question mark over the future of …
Bennett appointed chairman of Monitor
February 18, 2011Sales and Marketing Monitor, NHS
Monitor, the body which will take on a powerful new role in regulating competition in the NHS, has a new …
Vidaza patient access scheme sways NICE
February 17, 2011Sales and Marketing Celgene, NICE, Vidaza
Celgene’s Vidaza has been recommended by NICE in final draft guidance issued today. Vidaza (azacitidine) is recommended as a treatment …
e-Therapeutics success in £17 million financing
February 17, 2011Research and Development, Sales and Marketing ETS2101, Invesco, e-Therapeutics
UK drug discovery and development company e-Therapeutics has successfully raised £17.6 million through a new share issue. The deal attracted …
Pharma industry R&D pipelines
February 16, 2011Research and Development pipeline, pipelines
New medicines which advance the treatment of diseases are the lifeblood of the pharmaceutical industry, and billions are invested by …
Lilly hails progress of new R&D approaches
February 16, 2011Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly
Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …
Companies join forces to promote AF awareness
February 16, 2011Medical Communications, Sales and Marketing AF, Multaq, Pradaxa, apixaban, atrial fibrillation
Boehringer Ingelheim and Sanofi-Aventis are to co-sponsor the World Heart Federation’s global atrial fibrillation (AF) education campaign. AF AWARE was …
Sanofi seals Genzyme deal for $20 billion
February 16, 2011Research and Development, Sales and Marketing Genzyme, Sanofi
Sanofi-Aventis has finally agreed a deal to buy Genzyme for $20.1 billion after eight months of wrangling with the US …
Sefton takes over at Ketchum Pleon healthcare
February 16, 2011Medical Communications Ketchum Pleon, PR, appointment, medical communications, recruitment
Ketchum Pleon, the leading communications consultancy in the UK and Europe, has announced today that Amanda Sefton has been named …
Obama’s generics plan criticised
February 15, 2011Sales and Marketing FDA, Obama, PhRMA, generics, reform
US pharma says new plans to end ‘pay-for-delay’ generics deals and shave five years from biologics exclusivity will threaten innovation …
Sartorius reaps rewards from Asian boom
February 15, 2011Manufacturing and Production
German lab and processing equipment group Sartorius reported a bumper year in 2010, with revenues up nearly 10% on the …
Merck repels jaw injury claim
February 15, 2011Sales and Marketing Fosamax, Merck, US, lawsuit
A New Jersey state court jury has found in favour of Merck & Co in the company’s ongoing legal battle …
US Senate takes aim at prescription drug shortages
February 15, 2011Manufacturing and Production Merck, Zostavax, shortages, supply chain
A bill aimed at tackling the ongoing problem of prescription drug shortages in the US has been introduced in the …
Insulin pens help Gerresheimer to record sales
February 15, 2011Manufacturing and Production Gerresheimer, glass, packaging, plastic
Gerresheimer has posted a bumper set of results in 2010, thanks to continuing strong demand for its glass and plastic …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
